FDC Ltd (FDC) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 248455,
    "name": "FDC",
    "stock_name": "FDC",
    "full_name": "FDC Ltd",
    "name_url": "stocks-analysis/fdc",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "412.10",
    "chg": -1.75,
    "chgp": "-0.42%",
    "dir": -1,
    "prev_price": "413.85",
    "mcapval": "6,709.40 Cr",
    "mcap": "Small Cap",
    "scripcode": 531599,
    "symbol": "FDC",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE258B01022",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "5.7 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/fdc-248455-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "FDC Sees Revision in Market Assessment Amidst Challenging Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/fdc-downgraded-to-strong-sell-by-marketsmojo-amid-weak-financials-and-bearish-technicals-3735239",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/FDC_mojoScore_3735239.png",
        "date": "2025-11-28 10:05:12",
        "description": "FDC, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market evaluation, reflecting shifts in its financial and technical outlook. This adjustment comes amid a backdrop of subdued operational performance and valuation concerns, prompting investors to reassess the stock’s position within its sector."
      },
      {
        "title": "Is FDC technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-fdc-technically-bullish-or-bearish-3713828",
        "imagepath": "",
        "date": "2025-11-19 08:14:07",
        "description": "As of 18 November 2025, the technical trend has changed from mildly bearish to bearish. The current technical stance for FDC is bearish with a moderate strength. Key indicators driving this stance include a bearish MACD on the weekly timeframe, bearish moving averages on the daily timeframe, and a bearish signal from Bollinger Bands on both weekly and monthly timeframes. The KST is also bearish on the weekly, reinforcing the negative outlook. Although the OBV shows a bullish signal on the monthly, it does not outweigh the overall bearish indicators...."
      },
      {
        "title": "FDC Technical Momentum Shifts Amid Bearish Indicators in Pharmaceuticals Sector",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fdc-technical-momentum-shifts-to-bearish-amidst-weak-price-performance-3714185",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/FDC_technicaldot_3714185.png",
        "date": "2025-11-19 08:02:02",
        "description": "FDC, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical parameters, reflecting a change in price momentum and market sentiment. Recent data reveals a transition from mildly bearish to bearish technical trends, with several indicators signalling adjustments in the stock’s evaluation."
      },
      {
        "title": "FDC Forms Death Cross Signalling Potential Bearish Trend in Pharmaceuticals Sector",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fdc-forms-death-cross-signalling-potential-bearish-trend-in-pharmaceuticals-sector-3712483",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/FDC_dealthcross_3712483.png",
        "date": "2025-11-18 18:00:39",
        "description": "FDC, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a technical event where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend, indicating potential long-term weakness and trend deterioration for the stock."
      },
      {
        "title": "How has been the historical performance of FDC?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-fdc-3676944",
        "imagepath": "",
        "date": "2025-11-06 22:44:01",
        "description": "Answer:\nThe historical performance of FDC shows a consistent growth trend in net sales and overall financial metrics over the years.\n\nBreakdown:\nFDC's net sales have increased from 1,090.70 Cr in Mar'19 to 2,108.12 Cr in Mar'25, reflecting a steady growth trajectory. The total operating income has similarly risen, reaching 2,108.12 Cr in Mar'25 from 1,090.70 Cr in Mar'19. However, the total expenditure has also grown, amounting to 1,783.32 Cr in Mar'25, up from 859.68 Cr in Mar'19. Operating profit (PBDIT) has fluctuated, peaking at 440.17 Cr in Mar'24 before dropping to 415.46 Cr in Mar'25. Profit before tax reached 357.22 Cr in Mar'25, while profit after tax was recorded at 266.79 Cr. The earnings per share (EPS) decreased from 18.75 in Mar'24 to 16.39 in Mar'25, indicating a decline despite the growth in sales. On the balance sheet, total assets increased from 1,812.93 Cr in Mar'20 to 2,713.80 Cr in Mar'..."
      },
      {
        "title": "Why is FDC falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-fdc-fallingrising-3676565",
        "imagepath": "",
        "date": "2025-11-06 21:24:00",
        "description": "As of 06-Nov, FDC Ltd's stock price is currently at 421.45, reflecting a decrease of 26.1, or 5.83%. The stock has been underperforming, having fallen consecutively for the last two days with a total decline of 8.66% during this period. It opened the day with a significant loss of 8.26% and reached an intraday low of Rs 405.2, marking a decline of 9.46%. The stock is trading below all its moving averages and has experienced high volatility today, with an intraday volatility of 5.16%. Additionally, there has been a notable drop in investor participation, with delivery volume decreasing by 41.32% compared to the five-day average. The company's financial performance is concerning, as it has shown poor long-term growth, with a decline in operating profit and net sales, alongside a low return on equity and a significant drop in profit after tax.\n\nIn the broader market context, FDC's short-term performance has be..."
      },
      {
        "title": "Are FDC latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-fdc-latest-results-good-or-bad-3676388",
        "imagepath": "",
        "date": "2025-11-06 19:15:04",
        "description": "FDC Limited's latest financial results for Q2 FY26 reveal significant operational challenges, marked by a sharp decline in both revenue and net profit. The company reported net sales of ₹473.03 crores, reflecting a quarter-on-quarter decrease of 27.05% and a year-on-year decline of 7.94%. This downturn in revenue is accompanied by a notable drop in operating profit, which fell to ₹33.82 crores from ₹140.35 crores in the previous quarter, indicating a substantial operational strain.\n\nThe operating margin, excluding other income, collapsed to 7.15%, down from 21.65% in Q1 FY26, representing the lowest level in recent history. This dramatic compression in margins suggests significant challenges related to cost management and pricing pressures within the pharmaceutical sector. Additionally, the profit after tax margin fell sharply to 6.00%, down from 18.72% in the previous quarter, further highlighting the pres..."
      },
      {
        "title": "FDC Faces Financial Challenges Amidst Declining Sales and Profit Metrics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fdcs-financial-trend-shifts-from-positive-to-negative-amid-significant-performance-decline-3675616",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/FDC_fintrenddot_3675616.png",
        "date": "2025-11-06 11:00:17",
        "description": "FDC, a small-cap pharmaceutical company, reported a challenging quarter ending September 2025, with net sales declining significantly and profit after tax dropping sharply. Despite achieving its highest operating cash flow, the company faces low return on capital employed and has underperformed against the Sensex over the past year."
      },
      {
        "title": "FDC Ltd Opens Weak with Gap Down Amid Market Concerns and Declining Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fdc-ltd-opens-weak-with-gap-down-amid-market-concerns-and-declining-trend-3675298",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/FDC_gapdown_3675298.png",
        "date": "2025-11-06 10:15:10",
        "description": "FDC Ltd, a small-cap pharmaceutical company, experienced a significant decline in stock price, continuing a downward trend over recent days. The stock is trading below key moving averages and has shown high volatility, with technical indicators suggesting a bearish outlook. Its performance contrasts sharply with the broader market."
      }
    ],
    "total": 200,
    "sid": "248455",
    "stock_news_url": "https://www.marketsmojo.com/news/fdc-248455"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "06-Nov-2025",
      "details": "Press Release for unaudited consolidated financial results for quarter and half year ended September 30 2025.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome For The Board Meeting Held On November 05 2025.",
      "datetime": "05-Nov-2025",
      "details": "Outcome for the board meeting held on November 05 2025.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Unaudited Standalone & Consolidated Financial Results For Quarter And Half Year Ended On September 30 2025",
      "datetime": "28-Oct-2025",
      "details": "FDC Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2025 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results for Quarter and Half Year Ended On September 30 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "FDC Ltd has declared <strong>500%</strong> dividend, ex-date: 22 Nov 24",
          "dt": "2024-11-22",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

FDC Sees Revision in Market Assessment Amidst Challenging Financial Trends

2025-11-28 10:05:12

FDC, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market evaluation, reflecting shifts in its financial and technical outlook. This adjustment comes amid a backdrop of subdued operational performance and valuation concerns, prompting investors to reassess the stock’s position within its sector.

Is FDC technically bullish or bearish?

2025-11-19 08:14:07

As of 18 November 2025, the technical trend has changed from mildly bearish to bearish. The current technical stance for FDC is bearish with a moderate strength. Key indicators driving this stance include a bearish MACD on the weekly timeframe, bearish moving averages on the daily timeframe, and a bearish signal from Bollinger Bands on both weekly and monthly timeframes. The KST is also bearish on the weekly, reinforcing the negative outlook. Although the OBV shows a bullish signal on the monthly, it does not outweigh the overall bearish indicators....

FDC Technical Momentum Shifts Amid Bearish Indicators in Pharmaceuticals Sector

2025-11-19 08:02:02

FDC, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical parameters, reflecting a change in price momentum and market sentiment. Recent data reveals a transition from mildly bearish to bearish technical trends, with several indicators signalling adjustments in the stock’s evaluation.

FDC Forms Death Cross Signalling Potential Bearish Trend in Pharmaceuticals Sector

2025-11-18 18:00:39

FDC, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a technical event where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend, indicating potential long-term weakness and trend deterioration for the stock.

How has been the historical performance of FDC?

2025-11-06 22:44:01

Answer: The historical performance of FDC shows a consistent growth trend in net sales and overall financial metrics over the years. Breakdown: FDC's net sales have increased from 1,090.70 Cr in Mar'19 to 2,108.12 Cr in Mar'25, reflecting a steady growth trajectory. The total operating income has similarly risen, reaching 2,108.12 Cr in Mar'25 from 1,090.70 Cr in Mar'19. However, the total expenditure has also grown, amounting to 1,783.32 Cr in Mar'25, up from 859.68 Cr in Mar'19. Operating profit (PBDIT) has fluctuated, peaking at 440.17 Cr in Mar'24 before dropping to 415.46 Cr in Mar'25. Profit before tax reached 357.22 Cr in Mar'25, while profit after tax was recorded at 266.79 Cr. The earnings per share (EPS) decreased from 18.75 in Mar'24 to 16.39 in Mar'25, indicating a decline despite the growth in sales. On the balance sheet, total assets increased from 1,812.93 Cr in Mar'20 to 2,713.80 Cr in Mar'...

Why is FDC falling/rising?

2025-11-06 21:24:00

As of 06-Nov, FDC Ltd's stock price is currently at 421.45, reflecting a decrease of 26.1, or 5.83%. The stock has been underperforming, having fallen consecutively for the last two days with a total decline of 8.66% during this period. It opened the day with a significant loss of 8.26% and reached an intraday low of Rs 405.2, marking a decline of 9.46%. The stock is trading below all its moving averages and has experienced high volatility today, with an intraday volatility of 5.16%. Additionally, there has been a notable drop in investor participation, with delivery volume decreasing by 41.32% compared to the five-day average. The company's financial performance is concerning, as it has shown poor long-term growth, with a decline in operating profit and net sales, alongside a low return on equity and a significant drop in profit after tax. In the broader market context, FDC's short-term performance has be...

Are FDC latest results good or bad?

2025-11-06 19:15:04

FDC Limited's latest financial results for Q2 FY26 reveal significant operational challenges, marked by a sharp decline in both revenue and net profit. The company reported net sales of ₹473.03 crores, reflecting a quarter-on-quarter decrease of 27.05% and a year-on-year decline of 7.94%. This downturn in revenue is accompanied by a notable drop in operating profit, which fell to ₹33.82 crores from ₹140.35 crores in the previous quarter, indicating a substantial operational strain. The operating margin, excluding other income, collapsed to 7.15%, down from 21.65% in Q1 FY26, representing the lowest level in recent history. This dramatic compression in margins suggests significant challenges related to cost management and pricing pressures within the pharmaceutical sector. Additionally, the profit after tax margin fell sharply to 6.00%, down from 18.72% in the previous quarter, further highlighting the pres...

FDC Faces Financial Challenges Amidst Declining Sales and Profit Metrics

2025-11-06 11:00:17

FDC, a small-cap pharmaceutical company, reported a challenging quarter ending September 2025, with net sales declining significantly and profit after tax dropping sharply. Despite achieving its highest operating cash flow, the company faces low return on capital employed and has underperformed against the Sensex over the past year.

FDC Ltd Opens Weak with Gap Down Amid Market Concerns and Declining Trend

2025-11-06 10:15:10

FDC Ltd, a small-cap pharmaceutical company, experienced a significant decline in stock price, continuing a downward trend over recent days. The stock is trading below key moving averages and has shown high volatility, with technical indicators suggesting a bearish outlook. Its performance contrasts sharply with the broader market.

View All News